Literature DB >> 22491693

Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010).

Angela Novais1, João Pires, Helena Ferreira, Luísa Costa, Carolina Montenegro, Claudia Vuotto, Gianfranco Donelli, Teresa M Coque, Luísa Peixe.   

Abstract

The characterization of a broad representative sample of ST131 Escherichia coli isolates from different origins and settings (1991 to 2010) revealed that this clonal group has likely diversified recently and that the expansion of particular variants has probably been favored by the capture of diverse, multidrug-resistant IncFII plasmids (pC15-1a, pEK499, pKF3-140-like). The low ability to adhere and to grow as biofilm that was detected in this study suggests unknown mechanisms for the persistence of this clonal group which need to be further explored.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22491693      PMCID： PMC3393462          DOI： 10.1128/AAC.00475-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  33 in total

1.  Characterization of plasmids encoding extended-spectrum β-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK.

Authors:  Michel Doumith; Hiran Dhanji; Matthew J Ellington; Peter Hawkey; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2011-12-29       Impact factor: 5.790

2.  Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants.

Authors:  Laura Villa; Aurora García-Fernández; Daniela Fortini; Alessandra Carattoli
Journal:  J Antimicrob Chemother       Date:  2010-10-08       Impact factor: 5.790

3.  Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli.

Authors:  Sally R Partridge; Zhiyong Zong; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

4.  Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings.

Authors:  Gemma Croxall; James Hale; Vivienne Weston; Georgina Manning; Phil Cheetham; Mark Achtman; Alan McNally
Journal:  J Antimicrob Chemother       Date:  2011-08-22       Impact factor: 5.790

5.  Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates.

Authors:  Azucena Mora; Alexandra Herrera; Rosalia Mamani; Cecilia López; María Pilar Alonso; Jesús E Blanco; Miguel Blanco; Ghizlane Dahbi; Fernando García-Garrote; Julia María Pita; Amparo Coira; María Isabel Bernárdez; Jorge Blanco
Journal:  Appl Environ Microbiol       Date:  2010-09-03       Impact factor: 4.792

6.  National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.

Authors:  Jorge Blanco; Azucena Mora; Rosalia Mamani; Cecilia López; Miguel Blanco; Ghizlane Dahbi; Alexandra Herrera; Jesús E Blanco; María Pilar Alonso; Fernando García-Garrote; Fernando Chaves; María Ángeles Orellana; Luis Martínez-Martínez; Jorge Calvo; Guillem Prats; María Nieves Larrosa; Juan José González-López; Lorena López-Cerero; Jesús Rodríguez-Baño; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2011-06-13       Impact factor: 5.790

Review 7.  Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods.

Authors:  Joanne L Platell; James R Johnson; Rowland N Cobbold; Darren J Trott
Journal:  Vet Microbiol       Date:  2011-05-13       Impact factor: 3.293

8.  Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain).

Authors:  Alicia Coelho; Azucena Mora; Rosalia Mamani; Cecilia López; Juan José González-López; María Nieves Larrosa; J Natalia Quintero-Zarate; Ghizlane Dahbi; Alexandra Herrera; Jesús E Blanco; Miguel Blanco; María Pilar Alonso; Guillem Prats; Jorge Blanco
Journal:  J Antimicrob Chemother       Date:  2010-12-21       Impact factor: 5.790

9.  Biofilm formation by and thermal niche and virulence characteristics of Escherichia spp.

Authors:  Danielle J Ingle; Olivier Clermont; David Skurnik; Erick Denamur; Seth T Walk; David M Gordon
Journal:  Appl Environ Microbiol       Date:  2011-02-18       Impact factor: 4.792

Review 10.  Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.

Authors:  Neil Woodford; Jane F Turton; David M Livermore
Journal:  FEMS Microbiol Rev       Date:  2011-03-01       Impact factor: 16.408
View more
  27 in total

1.  Blue-carba, an easy biochemical test for detection of diverse carbapenemase producers directly from bacterial cultures.

Authors:  J Pires; A Novais; L Peixe
Journal:  J Clin Microbiol       Date:  2013-10-09       Impact factor: 5.948

2.  Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.

Authors:  Gisele Peirano; Akke K van der Bij; Joshua L Freeman; Laurent Poirel; Patrice Nordmann; Michael Costello; Veronika L Tchesnokova; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

3.  Antibiotic-resistant Klebsiella pneumoniae and Escherichia coli high-risk clones and an IncFII(k) mosaic plasmid hosting Tn1 (blaTEM-4) in isolates from 1990 to 2004.

Authors:  Irene Rodríguez; Ângela Novais; Felipe Lira; Aránzazu Valverde; Tânia Curião; José Luis Martínez; Fernando Baquero; Rafael Cantón; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

4.  Toxin Kid uncouples DNA replication and cell division to enforce retention of plasmid R1 in Escherichia coli cells.

Authors:  Belén Pimentel; Radhika Nair; Camino Bermejo-Rodríguez; Mark A Preston; Chukwuma A Agu; Xindan Wang; Juan A Bernal; David J Sherratt; Guillermo de la Cueva-Méndez
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

Review 5.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

6.  Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

Authors:  Yohei Doi; Yoon Soo Park; Jesabel I Rivera; Jennifer M Adams-Haduch; Ameet Hingwe; Emilia M Sordillo; James S Lewis; Wanita J Howard; Laura E Johnson; Bruce Polsky; James H Jorgensen; Sandra S Richter; Kathleen A Shutt; David L Paterson
Journal:  Clin Infect Dis       Date:  2012-11-13       Impact factor: 9.079

Review 7.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

8.  An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum β-lactamase-producing lineage in the Copenhagen area.

Authors:  J B Nielsen; A Albayati; R L Jørgensen; K H Hansen; B Lundgren; K Schønning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-06       Impact factor: 3.267

9.  MALDI-TOF mass spectrometry as a tool for the discrimination of high-risk Escherichia coli clones from phylogenetic groups B2 (ST131) and D (ST69, ST405, ST393).

Authors:  Â Novais; C Sousa; J de Dios Caballero; A Fernandez-Olmos; J Lopes; H Ramos; T M Coque; R Cantón; L Peixe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-07       Impact factor: 3.267

10.  Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India.

Authors:  Arif Hussain; Amit Ranjan; Nishant Nandanwar; Anshu Babbar; Savita Jadhav; Niyaz Ahmed
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.